You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
4 March 2026 - Biotechnology company Allergy Therapeutics plc (AIM: AGY) on Wednesday reported positive biomarker results from its Phase I/IIa PROTECT trial of VLP Peanut, following the achievement of the study's primary safety endpoint.The tria...
4 March 2026 - Chinese biotechnology company Sino Biological Inc (SZ:301047) announced on Wednesday that it has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelerate vaccine development.This follows the World Heal...
3 March 2026 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Tuesday announced a definitive agreement to acquire privately held Corstasis Therapeutics Inc, adding Enbumyst (bumetanide nasal spray) to its car...
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (now Bristol Myers Squibb), within the oncology the...
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...
2 March 2026 - Life science company ValiRx PLC (AIM: VAL) revealed on Monday that it has established a wholly owned subsidiary, ValiRx Animal Health Limited, to develop and commercialise its oncology assets within the veterinary market.The new entity...